Study to Compare Pharmacokinetics of Tacrolimus Prolonged-release (PR) Capsules and Advagraf® PR Capsules in Stable Kidney Transplant Patients.

Exclusion Criteria

• •Evidence or suspicion of ongoing or persistent, acute or chronic rejection;
• •Requirement for dialysis within the six months prior to study entry;
• •Glomerular filtration rate (GFR) \<30 mL/min
• •Pregnant or breastfeeding women, confirmed by a positive human chorionic gonadotropin (hCG) laboratory test;
• •Intolerance to tacrolimus, excipients (including lactose, fructose or galactose), or similar products;